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ABSTRACT
Objective: Patient controlled sedation (PCS) has been shown to be a valid choice for sedation
during endoscopic retrograde cholangiopancreatography (ERCP) in randomized studies.
However, large scale studies are lacking.
Material and Methods: A single center, prospective observational study to determine how
sedation for ERCP is administered in clinical setting. All 956 patients undergoing 1196 ERCPs
in the endoscopy unit of Helsinki University Central Hospital 2012-2013, methods of sedation
and adverse events associated with different sedations were recorded.
Results: PCS was attempted a total of 685 times (57%), successful use of PCS was achieved
with 526 patients (77% of attempts). PCS device was operated by the anesthesiologist or
anesthesia nurse 268 times (22%). PCS was more likely chosen for younger (80.6% for <=60
years vs. 63.8% for >60 years, P<.001) patients and by trainee anesthetists. Anesthesiologist
administered propofol sedation was used 240 times (20%). The risk of failure of PCS was
increased, if systolic arterial pressure was <90 mmHg, dosage of PCS >17 ml, duration of
procedure exceeded 23 min. The risk of failure was lower in patients with primary sclerosing
cholangitis (PSC) and if sedation was deeper RASS <=-2. Uneventful PCS was associated
with less respiratory and cardiovascular depression than other methods. There were no
statistically significant differences in safety profiles with all the methods of sedation.
Conclusions: PCS is readily implemented in clinical practice, is suitable for younger and low
risk patients and is associated with less cardiorespiratory adverse effects.
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Introduction
Endoscopic retrograde cholangiopancreatography (ERCP) is one of the most demanding
endoscopic procedures that usually cannot be performed without deep sedation or general
anesthesia because of substantial procedural discomfort and pain (1-3).  There is no
agreement on the best method of anesthetic care for ERCP. Traditionally patients undergoing
ERCP have been sedated with benzodiazepines and opioids administered by the
endoscopists (3). This practice is being replaced by propofol sedation. However, in many
countries the presence of an anesthesiologist is required when administering propofol
sedation (4).
We have recently shown patient controlled sedation (PCS) with propofol and alfentanil is a
feasible and well-accepted method of delivering adequate sedation during ERCP (5). In PCS
the patient can adjust the level of sedation at will by taking incremental doses of sedative and
analgesic drugs with a remote-control unit connected to the infusion device. PCS is a method
which offers individual sedation for each patient and procedure. The method has not been
studied only in sedation for ERCP but also in various minimally or moderately invasive and
painful procedures such as interventional radiology (6), colonoscopy or change of dressings
for more than fifteen years (7-9).
Large scale prospective studies about the use of different methods and PCS for ERCP
sedation are lacking. In addition, it is not known how well PCS is adopted in clinical practice.
This study was carried out in order to assess the use of PCS and other methods of sedation
and their relative safety during ERCP in an endoscopic unit of Meilahti Hospital, a tertiary
university clinic, where over 1200 ERCP procedures are performed annually and in which also
PCS is available. Our particular interest was also to analyze which factors influence on the
choice of the sedation method.
Methods
This study was approved by the institutional Ethics Committee of Helsinki University Central
Hospital (Ethics Committee, Department of Surgery, Biomedicum Helsinki 2 C, Tukholmankatu
8 C, PL 705, 00029 HUS, Finland. DNRO 180/13/02/2011) on March 21st, 2012. Informed
consent was waived due to non-interventional observational nature of the study by the Ethics
Committee.
1228 ERCPs were attempted at the hospital during the 12-month period from March 1st, 2012
to February 28th, 2013. All the adult patients who were treated in the endoscopy unit were
included in the study.
The following data of each patient was registered in a prospective manner: age, weight,
height, American Society of Anesthesiology physical status classification (ASA), indications,
cannulation method, performed procedures, duration of the procedure, sedation details  (use
of PCS, administration of the sedative by the patient, anesthesiologist or other members of the
staff, other methods of sedation, consumption of sedative medication). Heart rate and oxygen
saturation (SpO 2) were recorded continuously and non-invasive blood pressure (NIBP) was
recorded automatically at 5 min intervals during the procedure. The level of sedation was
assessed using the Richmond Agitation-Sedation Scale (RASS) (10) (see Table 1): before the
procedure, the deepest level of sedation during the procedure and after the procedure before
transfer to recovery room were registered. Use of other medications (vasoactive medication:
β-blockers, phenylephrine, naloxone or doxapram, local anesthetic of the pharynx, other
medication), the need for mask ventilation, intubation, stopping the procedure for reasons
related to anesthesia were recorded. ERCP adverse events (pancreatitis, bleeding,
perforation, other), 1- day and 30-day mortality were recorded. Respiratory depression was
defined as SpO 2 below 90% and cardiovascular depression was defined as systolic blood
pressure below 90mmHg. In addition, drug related allergic reactions and malfunctions of drug
delivery systems, oxygen supply and monitoring devices and other potential sedation related
events were registered.
Sedation was administered according to standard clinical practice. An anesthetic nurse and an
anesthesiologist were in charge of delivering and monitoring the sedation. For PCS, a syringe-
driver with a self-administration unit (Syramed μSP6000; Arcomed AG, Regensdorf,
Switzerland) was prepared with propofol and alfentanil to achieve the following concentrations:
propofol 8mg/ml and alfentanil 0.06mg/ml. A patient could take a 1 ml dose of this solution
when needed, no lock-out time or dose-limit was programmed. Other methods available for
sedation were traditional propofol sedation, ketamine, midazolam, fentanyl and alfentanil. The
aim was to maintain spontaneous ventilation for each patient. Although PCS was considered
the method-of-choice for ERCP, anesthesiologists could freely choose the method of sedation
according to their own preferences and the needs of the individual patient.
For the purposes of this study we considered PCS to have been successful, if no other forms
of sedation or analgesics were needed apart from initial dose of fentanyl or alfentanil before
initiation of the procedure and if an anesthetic nurse or anesthesiologist didn’t have to
intervene with PCS. If the anesthesia team had to intervene, the method of sedation was
considered PCS and anesthesiologist administered sedation (AAS)
Primary endpoints were choice of sedation and successful use of PCS. Secondary endpoints
were respiratory and cardiovascular depression and the consumption of sedatives and opioids
The results are reported as medians and interquartile ranges (median [IQR]) or number of
patients and percentages. Logistic regression analysis was used to assess the risk of failure.
Non-normal data was divided at the median for this analysis. Multivariate analysis was
adjusted by age and sex. The variable was included into the multivariate analysis, if p-value
was <0.05 in the univariate analysis. Forward stepping was used with p<0.05 criteria to
include the variable in to the multivariate model. Statistical calculations were generated using
IBM SPSS Statistics 19 (International Business Machines Corporation, Endicott, NY, USA).
Results
We excluded 15 ERCPs performed in the operation theatre and 17 ERCPs performed for
children and adolescents under 18 years of age. 956 patients with 1196 ERCPs were left in
our analysis. Two gastroenterologists performed 253 ERCPs for cases with suspected or
diagnosed primary sclerosing cholangitis (PSC) and 4 gastrointestinal surgeons performed
943 ERCP procedures with other indications. All patients were in prone position during the
procedure. Characteristics of the 1196 ERCPs are shown in Table 2. Demographics and the
cardiorespiratory parameters and drug consumption are shown in Table 3. Sedation levels can
be seen in Figure 1.
Median age of the 956 patients was 59.0 [25] years and median BMI 24.8[6.2] kg/m2,
529(55%) were male and 427(45%) female. The median length of the procedure was 23[19]
minutes. There were 299(25%) procedures regarded as emergency ERCPs.
Attempted ERCP did not succeed in 33 out of 1196 procedures. In 20 procedures papilla was
not reached or found (postoperative state (gastric resection, pancreaticoduodenectomy) (n=5),
obstruction proximal to papillary region (n=6), oedema of the descending duodenum (n=8) and
one ERCP could not be performed due to patient’s allergy to sedatives. In 13 cases papilla
was reached but the desired duct couldn't be cannulated.
Methods of Sedation
PCS was attempted 685(57%) times out of the 1196 procedures.  Successful use of PCS was
achieved in 77% (526 of 685) of PCS attempts i.e. 44% of all procedures. Propofol sedation or
anesthesiologist administered PCS solution over PCS was more likely chosen when the
patient was over 60 years old (137/378, 36.2% for >60 vs. 107/551, 19.4% for ≤60 years old, P
< .001), was female (116/377, 30.8% for female vs. 128/552, 23.2% for male, P = .012), a
surgical patient (223/692, 32.2% for surgical vs. 20/235, 8.5% for gastroenterological patient,
P < .001), or had high ASA classification (≥4) (55/92, 59.8% for ≥4 vs. 189/837, 22.6% for <4,
P < .001).
Patients with PCS used less propofol (140 (110) mg for PCS vs 189 (216) mg for others,
p<0.001) and tolerated the procedure with lower level of sedation (RASS ≤ -2, 153/575, 26.6%
for PCS vs 99/207, 47.8% for others, p<0.001) than patients with propofol sedation or
anesthesiologist administered PCS solution
The multivariate analysis of PCS success adjusted for age and sex (Table 4) revealed that risk
of failure increased if the dosage of PCS solution increased to over 17 ml (propofol 136mg,
alfentanil 1,02mg) (OR 1.9, 95% CI 1.2-3.3, p=0.009), duration of procedure increased over 23
min (OR 1.7, 95% CI 1.0-2.7, p=0.042), systolic arterial pressure (SAP) lower that 90mmHg
during the procedure (OR 2.2, 95% CI1.1-4.7, p=0.037). The risk of failure was decreased with
PSC patients (OR 0.3, 95% CI 0.1-0.5. p<0.0001) and if the level of sedation was (RASS) ≤ -2
(OR 0.2 0.1-0.4, p<0.0001).
One patient was sedated with only ketamine and midazolam (15mg and 7mg, i.v. respectively)
due to severe allergies of the patient. The level of sedation was insufficient, and the procedure
had to be cancelled.
Two patients received only small doses of opioids. One refused sedative medication and only
received fentanyl 0.1mg i.v., the other was a frail old woman and became adequately sedated
with a bolus of fentanyl 0.75mg and alfentanil 0.5mg i.v.
Attending anesthesiologist
Attending anesthesiologist was a specialist in 579(48%) of cases and an anesthesiologist in
training in 617(52%) of cases. Patients treated by specialists were slightly older than those
treated by trainees (61[26] vs. 58[25] years; P=.028).  Also, their ASA status was slightly
higher (ASA≥3 in 386(67%) vs. 358(58%) (P=.002). Propofol sedation was used more by
specialist anesthesiologists (169/467 36.2%, P <.001) than anesthesiologists in training
(75/462, 16.2%) whereas PCS was used more by those in training (387/462, 83.8% vs
298/467 63.8%). PCS device operated by the anesthesiologist was not significantly different
between trainees and specialists (155/542 vs. 113/411, P=.72).
Anesthesiological Adverse Events
The incidence of respiratory depression was 129:1000 (31 of 240) under conventional propofol
sedation, while the incidence of respiratory depression in patients successfully using PCS was
86:1000 (45 of 526). In cases of PCS and AAS, the incidence of respiratory depression nearly
doubled to 151:1000 (24 of 159). With all attempts of PCS, the incidence of respiratory
depression was 101:1000 (69 of 685). With anesthesiologist or anesthesia nurse operated
PCS solution administration the incidence of respiratory depression was 104:1000 (28 of 268).
PCS and AAS was associated with respiratory depression (P=.024), when compared to
successful use of PCS.
The incidence of cardiovascular depression was 75:1000 (18 of 240) with patients who
received propofol sedation. With successful PCS the incidence of cardiovascular depression
was 42:1000 (22 of 526). With PCS and AAS, the incidence of cardiovascular depression was
126:1000 (20 of 159). With all attempts at PCS the incidence of cardiovascular depression
was 61:1000(42 of 685).  With anesthesiologist or anesthesia nurse operated PCS solution
administration the incidence of cardiovascular depression was 97:1000 (26 of 268) of patients.
Ephedrine 5-10mg i.v. bolus was used on 10 patients (3 patients using PCS successfully, 3
patients with PCS and AAS, 1 with anesthesiologist administered PCS and 3 using propofol
sedation), and phenylephrine 0.1mg i.v. boluses on 13 patients (8 patients with
anesthesiologist administered PCS and 2 patients with propofol sedation). One patient
receiving anesthesiologist administered PCS was given etilefrine 8mg i.v.  Two patients
received i.v. epinephrine as part of resuscitation (see next paragraph). Unsuccessful use of
PCS was associated with cardiovascular depression (P<.001), when compared to successful
use of PCS.
The procedure had to be paused because of anesthesia related reasons (mask ventilation) 15
times: on 10 (1,5 %) patients using PCS, two of which subsequently continued with PCS, eight
were converted to anesthesiologist-controlled sedation with PCS solution. 5 patients (2,1%)
required mask ventilation under conventional propofol sedation. Mask ventilation was not
needed under anesthesiologist administered PCS solution. 3 patients were intubated (one
case of air embolism leading to resuscitation, one case of laryngobronchospasm that first was
diagnosed as anaphylaxis and one ICU patient with septic cholecystitis, already intubated
upon arrival to endoscopy room). No other adverse effects directly related to given sedation
were observed.
Degree of difficulty of ERCP
Difficulty of ERCP was assessed using Schutz scale (11). Distribution between the different
sedation groups is shown in Table 5.
ERCP adverse events and mortality
There were altogether 99 adverse events in 956 patients. Out of 1196 planned ERCP, in 1176
cases papillary or anastomosis was reached for ERCP. Post-ERCP pancreatitis developed
after 32 out of 1176 ERCPs, (2.7%). Fifteen of them were categorized as mild, 13 moderate
and 4 severe (12). The rate of post-ERCP pancreatitis in native papilla cases was 14(2.5%).
Post-sphincterotomy bleeding occurred after 15 out of 1176 ERCP (1.3%). Four periampullary
perforations (0.3%) were treated conservatively. No luminal perforation occurred. Additionally,
12 patients (1%) with guide wire-induced perforations received antibiotics.  Twelve patients
(1.0%) were treated with antibiotics due to post-ERCP cholangitis. Additionally, 19
miscellaneous adverse events (1.6%; pseudocyst infection, stent migration, stent rupture,
peptic ulcer bleeding, air embolism, etc.) and 5 cardiopulmonary adverse events (0.4%, heart
attack, pulmonary embolism,) occurred.
Two patients died the same day ERCP was performed (one with air embolism caused by gas
insufflation during endoscopy, and one elderly patient with heart attack). Eleven patients died
in a week after the procedure (1%) and 30-day mortality was 44 (4.6%).  Mortality could not be
directly associated with given sedation.
Discussion
The need for ERCP has been estimated to be about 50-100 per 100 000 persons per year and
seems to be rising as more and more therapeutic options become available (13, 14).
Therefore it is important to determine how these procedures can be performed in a timely
manner without compromising patient comfort and, more importantly, safety.
This study has shown, that PCS has a good safety profile during ERCP procedures also in
normal clinical setting outside strict research protocols. Patients using PCS consumed less
sedatives and tolerated the procedure with lighter level of sedation when compared with
anesthesiologist administered PCS solution or conventional propofol sedation which is in
accordance with our previous controlled study. This could lead to faster recovery for the
patient and facilitate a faster patient stream in the endoscopy unit.  However, this was not
explored in this study and warrants further studies.
Interestingly, the patients who could successfully self-administer sedative solution with PCS-
device were younger and treated by a trainee-anesthesiologist than those who did not. In
order to use PCS successfully the patient needs to be taught how to use it. It could be that the
trainees gave the patients more thorough information on the method and thus facilitated the
success. The attending anesthesiologist was free to choose the method of sedation which he
or she provided. The investigators made no effort to influence this choice. Also, the patients
were free to choose whether they wanted to use PCS or not, provided that they were capable
of making the decision. Previous studies have provided evidence that PCS is also suitable for
elderly patients (16-18), in this study there was no significant effect of age on PCS success
There was a major discrepancy in the success rate of PCS in patients with other indications
when compared with PSC patients. This is at least in part due to the procedural technical
differences. Higher pressure is used in biliary or pancreatic dilatations of other patients than in
patients with sclerosing cholangitis, thus making the procedure considerably more painful.
Also, the gastroenterological patients with sclerosing cholangitis were significantly younger
and healthier as described by the ASA physical status. We believe that younger patients were
encouraged to the use of PCS as opposed to other forms of sedation.
Although there were no other statistically significant differences in respiratory or
cardiovascular depression between the groups in our study, there was a trend toward fewer
adverse events with PCS as opposed to conventional propofol sedation, the incidence of mask
ventilation was 15:1000 and 21:1000 in patients sedated with PCS and anesthesiologist
administered propofol, respectively in the current study. We hypothesize that this may be
related either to the solution used in PCS or to the lack of patients´ training of using PCS prior
the procedure.  The present combination of propofol and alfentanil appeared safe in our
previous study (5) but obviously there is a need for further studies about the most appropriate
composition of sedatives and opioids in the PCS-solution. Patient education is also of
paramount importance in order for PCS to be successful, since the patient is the one
administering the sedation. Also the staff needs to be properly informed on the method in
order to be able to counsel the patient in the use of PCS. Some anesthesiologists or nurses
received only written instructions about the method. Interestingly mask ventilation was not
needed at all when PCS solution was administered by an anesthesiologist while mask
ventilation was required occasionally when traditional propofol sedation was used, yet
traditional propofol sedation is the method anesthesiologists are most familiar with. The
reason for this remains unclear. Regarding the overall cardiovascular safety of PCS, our
findings are in concurrence with previous studies on the safety of PCS during ERCP (5, 15,
19).
One of the advances of the PCS is that it can be easily converted to a nurse or an
anesthesiologist administered administration of sedation simply by taking control of the self-
administration unit. This occurred in 132 of the procedures in the present study. Nurse
administered propofol sedation has been shown to be safe and effective for ERCP and variety
of other procedures (20-23). While not the purpose or within the scope of this study, one could
surmise that PCS could be delivered by trained nurse specialists, at least to younger and
healthier patients. Naturally a nurse specialist would have to be trained to manage sedation
related adverse events such as cardiorespiratory depression even though adverse event rates
for different methods of sedation were similar and reasonably low and serious adverse events
were rare and not associated with any particular method of sedation
PCS has been available in our institution for several years and has been shown in several
studies – even ones performed in our own institution (15, 19) - to be a valid choice for sedating
ERCP patients. Even so, according to the survey we made, traditional propofol sedation was
more likely chosen by our anesthesiologists, both trainees and specialists. It has been
previously shown that changing doctors' clinical routines with evidence based medicine is
difficult (24) and needs an active approach (25). While there still isn't a consensus on what
type of anesthetic care is the best for ERCP, the small number of anesthesiologists using PCS
does raise the question, whether more education on the subject would be warranted.
This study does have its limitations. It is a single center study so the findings may not be
universally applicable. However, there is a constantly changing pool of senior
anesthesiologists and trainees in anesthesiology administering sedation for ERCP procedures.
Another drawback is, that we did not record why propofol sedation or anesthesiologist
administered PCS-solution was chosen over PCS by the anesthesiologist, even though PCS
was considered as the method-of-choice.  This was a conscious decision on our part as to not
influence the decision-making process and thus make PCS more likely to have been chosen
than it otherwise would have been. There is also the risk of selection bias in this study due to
the lack of randomization of the different groups. Further randomized prospective studies are
undoubtedly needed to identify the most optimal patients for PCS. Finally, we didn’t investigate
patient preferences or satisfaction with different methods of sedation even though this is an
important question when it comes to choosing the method of sedation. Our previous studies
(5, 15, 19) and clinical experience have shown however, that patients are usually highly
satisfied with PCS and would choose the same method of sedation again, if needed.
In conclusion, both anesthesiologist administered sedation and PCS were found to be
effective and safe during ERCP. Successful use of PCS leads to lower consumption of
sedatives and lighter level of sedation, which may facilitate faster patient recovery.
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Tables
Table 1. Richmond Agitation Sedation Scale
-5 Unarousable, no response to voice, physical stimulation or pain
-4 Deep sedation, responds only to pain (such as bile duct dilatation)
-3 Moderate sedation, responds to physical stimulation (such as shaking,
manipulation of the gastroscope)
-2 Light sedation, responds to repeated loud voice, eyes open <10 seconds
-1 drowsy, not fully alert, but has sustained awakening
(eye-opening/eye contact) to voice (>10 seconds)
0 Alert and calm
1 Restless, anxious but movements not aggressive, vigorous
2 Agitated, frequent non-purposeful movement, fights the procedure
3 very agitated, pulls or removes catheters; aggressive
4 Combative, violent, immediate danger to staff
Table 2. ASA class and number of attempted ERCPs performed to 956 adult patients attending ERCPs
in Meilahti endoscopy unit during March 1st, 2012 to February 28th, 2013
ASA class Number (%) of patients
 n = 956
ASA I 31(3)
ASA II 347(36)
ASA III 450(47)
ASA IV-V 128(13)
Number of ERCP:s performed
1 787 (82)
2 116(12)
3 42(4)
≥4 11(2)
 ASA= American Society of Anesthesiology physical status classification; ERCP= endoscopic
retrograde cholangiopancreatography

Table 3. Demographics, drug consumption and incidence of hypoxemia and hypotension of the patients
PCS
n=526
PCS + AAS
n=159
PCS
administered by
Anesthesiologist
/nurse
n=268
AAS
n=240
Duration; minutes
(IQR)
22(17) 26 (27) 22 (21) 23 (19)
age; years(IQR) 53 (24) 58 (22) 69 (28) 63( 18)
ASA class (%) I: 22 (4.2)
II: 232 (44.1)
III:247 (47.0)
IV: 25 (4.8)
V: 0
I: 4 (2.5)
II: 63 (39.6)
III:80 (50.3)
IV: 12 (7.5)
V: 0
I: 4 (1.5)
II: 50 (18.7)
III:144 (53.7)
IV: 69 (25.7)
V: 1 (0.4)
I: 5 (2.1)
II: 71 (29.6)
III:110 (45.8)
IV: 53 (22.1)
V: 1 (0.4)
BMI kg/m2 (IQR) 25.2 (6.0) 24.3 (5.7) 24.5 (6,1) 24.8 (6.7)
drug consumption:
PCS solution; ml
(IQR)
17 (14) 21 (15) 13 (12) -
Propofol infusion
or boluses:
Number of  times
used
- 30 14 240
Dosage of
propofol infusion
and/or boluses;
mg (IQR)
- 80 (150) 80 (50) 195 (203)
Total propofol
dosage including
PCS; mg (IQR)
133 (112) 176 (127) 104 (104) 195 (203)
Fentanyl
number of times
used
453 138 224 184
dosage; mg (IQR) 0.05 (0) 0.05 (0) 0.05 (0) 0.05 (0.05)
Alfentanil (in
addition to PCS
solution)
Number of times
used
2 11 7 50
dosage; mg (IQR) 0.75 (0.25) 0.5 (0) 0.5 (0.05) 0.5 (0.5)
total Alfentanil
dosage mg (IQR)
1.0 (0.84) 1.29 (0.89) 0.78 (0.72) 0.5 (0.5)
Ketamine
Number of  times
used
- 20 21 8
dosage; mg (IQR) - 12.5 (7.5) 16.3 (10.0) 22.5 (8.8)
Hypoxemia;
incidence
86:1000 151:1000 104:1000 129:1000
Hypotension;
incidence
42:1000 126:1000 97:1000 75:1000
PCS = Patient Controlled Sedation, PCS + AAS = Patient controlled Sedation and Anesthesiologist
Administered Sedation, AAS= Anesthesiologist Administered Sedation, IQR = Inter Quartile Range,
ASA class = American Society of Anesthesiology physical status classification, BMI = Body Mass
Index, SpO2 = Peripheral Oxygen saturation, Hypoxemia = SpO2 <90%, Hypotension = Systolic
arterial pressure <90mmHg
Table 4 Univariate and multivariate logistic regression analysis of PCS success
95% CI
Univariate ODDS lower Upper p
Age >60 years 1.5 1.0 2.1 0.037
Gender male 1.3 0.9 1.9 0.158
Dosage of PCS > 17 ml 1.9 1.3 2.7 0.001
Duration of procedure >23 min 1.8 1.2 2.6 0.002
RASS <= -2 0.3 0.2 0.4 0.000
Systolic arterial pressure (SAP) < 90mmHg 3.3 1.7 6.2 0.000
Bile duct stricture 1.6 1.1 2.3 0.015
Primary sclerosing cholangitis 0.5 0.3 0.7 0.000
Common bile duct stone 0.8 0.5 1.4 0.444
Post laparoscopic cholecystectomy 0.9 0.3 2.7 0.819
Post liver transplant 0.5 0.1 1.6 0.216
Chronic pancreatitis 1.6 1.0 2.4 0.047
Acute pancreatitis 0.9 0.2 3.3 0.873
Pancreatic duct stone 1.3 0.7 2.4 0.369
Multivariate
Age >60 years 1.2 0.8 1.9 0.415
Gender male 1.4 0.9 2.1 0.165
Dosage of PCS > 17 ml 2.0 1.2 3.3 0.009
Duration of procedure >23 min 1.7 1.0 2.7 0.042
RASS <= -2 0.2 0.1 0.4 0.000
Systolic arterial pressure (SAP) < 90mmHg 2.2 1.1 4.7 0.037
Primary sclerosing cholangitis 0.3 0.1 0.5 0.000
Table 5. Degree of Difficulty of ERCP
Degree of difficulty: degree of difficulty of ERCP according to Schutz scale (11)
Method of Sedation
degree of difficulty
Total1 2 3 4
PCS successful Count 210 158 136 22 526
% within sedation group 39,9% 30,0% 25,9% 4,2% 100,0%
% within degree of difficulty 63,3% 32,6% 41,8% 42,3% 44,1%
% of Total 17,6% 13,2% 11,4% 1,8% 44,1%
PCS Anesthetist/Nurse Count 43 134 79 12 268
% within sedation group 16,0% 50,0% 29,5% 4,5% 100,0%
% within degree of difficulty 13,0% 27,7% 24,3% 23,1% 22,5%
% of Total 3,6% 11,2% 6,6% 1,0% 22,5%
PCS unsuccessful Count 45 49 57 8 159
% within sedation group 28,3% 30,8% 35,8% 5,0% 100,0%
% within degree of difficulty 13,6% 10,1% 17,5% 15,4% 13,3%
% of Total 3,8% 4,1% 4,8% 0,7% 13,3%
Propofol sedation Count 34 143 53 10 240
% within sedation group 14,2% 59,6% 22,1% 4,2% 100,0%
% within degree of difficulty 10,2% 29,5% 16,3% 19,2% 20,1%
% of Total 2,8% 12,0% 4,4% 0,8% 20,1%
Total Count 332 484 325 52 1193
% within degree of difficulty 100,0% 100,0% 100,0% 100,0% 100,0%
% of Total 27,8% 40,6% 27,2% 4,4% 100,0%

Table 6. Results of the survey on anesthesiologists' attitudes regarding sedation
Specialists (n=16) Trainees (n=8)
Sedations/month, mean(SD) 2(1,3) 3(1,0)
PCS method of choice 6 (38%) 1 (13%)
Propofol sedation method of choice 11 (69%) 7 (88%)
Perceived problems with PCS:
Uneven anesthesia 8 (50%) 2 (25%)
Restlessness/anxiety 4 (25%) 3 (38%)
Lack of co-operation 9 (56%) 4 (50%)
Respiratory depression 2 (13%) 0
Slow onset of sedation after bolus 0 1 (13%)
PCS not suitable for patients with:
Dementia/lowered cognitive capabilities/old age 5 (31%) 3 (38%)
ASA 4-5 6 (38%)
Alcoholism/drug abuse 4 (25%) 1 (13%)
Risk of aspiration 2 (13%)
Chronic pain 1 (6%)  1 (13%)
Could nurses be able to sedate ERCP patients alone
Never under any circumstances 2 (13%) 1 (13%)
Yes, if adequate intructions and guidelines are provided 5 (31%) 1 (13%)
Yes, if an anesthesiologists is immediately available 12 (75%) 6 (75%)
Yes, but only with PCS 2 (13%) 2 (25%)
 PCS = Patient Controlled Sedation, ASA class = American Society of Anesthesiology physical status
classification, ERCP = Endoscopic Retrograde Cholangiopancreatography
Figures
Figure 1. Sedation levels
PCS during ERCP:  Lowest RASS score of patients using PCS during the procedure
PCS after ERCP: Lowest RASS score of patients using PCS after the procedure
Other during ERCP:  Lowest RASS score of anesthesiologist administered PCS solution or
anesthesiologist administered propofol sedation during the procedure.
Other after ERCP: Lowest RASS score of anesthesiologist administered PCS solution or
anesthesiologist administered propofol sedation after the procedure.
Number of patients is shown on the Y-axis.
RASS: Richmond Agitation-Sedation Scale
